Details for New Drug Application (NDA): 020155
✉ Email this page to a colleague
The generic ingredient in VIDEX is didanosine. There are eight drug master file entries for this compound. Additional details are available on the didanosine profile page.
Summary for 020155
Tradename: | VIDEX |
Applicant: | Bristol Myers Squibb |
Ingredient: | didanosine |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020155
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SOLUTION;ORAL | Strength | 100MG/PACKET | ||||
Approval Date: | Oct 9, 1991 | TE: | RLD: | No |
Profile for product number 004
Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SOLUTION;ORAL | Strength | 167MG/PACKET | ||||
Approval Date: | Oct 9, 1991 | TE: | RLD: | No |
Profile for product number 005
Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SOLUTION;ORAL | Strength | 250MG/PACKET | ||||
Approval Date: | Oct 9, 1991 | TE: | RLD: | No |
Expired US Patents for NDA 020155
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bristol Myers Squibb | VIDEX | didanosine | FOR SOLUTION;ORAL | 020155-006 | Oct 9, 1991 | ⤷ Sign Up | ⤷ Sign Up |
Bristol Myers Squibb | VIDEX | didanosine | FOR SOLUTION;ORAL | 020155-003 | Oct 9, 1991 | ⤷ Sign Up | ⤷ Sign Up |
Bristol Myers Squibb | VIDEX | didanosine | FOR SOLUTION;ORAL | 020155-004 | Oct 9, 1991 | ⤷ Sign Up | ⤷ Sign Up |
Bristol Myers Squibb | VIDEX | didanosine | FOR SOLUTION;ORAL | 020155-004 | Oct 9, 1991 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription